International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 2.4.2021
nurse meeting with elderly patient at home with mask
webinar with dr durie and sue dunnett headshots
Register Now for This FREE “Living Well with Myeloma” Webinar on Resilience
On Thursday, February 25, 2021, the IMF will host a FREE “Living Well with Myeloma” Webinar on “Building Your Resilience During Challenging Times” at 11:00 a.m. PT / 2:00 p.m. ET. Featured speakers are IMF Chairman of the Board Dr. Brian G.M. Durie and Dr. Susan Dunnett, a Senior Lecturer at the University of Edinburgh in Scotland. This uplifting sixty-minute webinar will include a segment for questions and answers from participants.
register button
people wearing masks in a meeting
European Medicines Agency Adopts Positive Opinion for Recommending Conditional Approval of NEXPOVIO (Selinexor)
On January 29, 2021 the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) “adopted a positive opinion recommending the conditional approval for NEXPOVIO® (selinexor) in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents, and an anti-CD38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.”
learn more
miles for myeloma virtual logo
The 13th Annual Miles for Myeloma 5K Run/Walk Goes Virtual Once Again
The 13th Annual Miles for Myeloma 5K Run/Walk is going virtual once again! This exciting style of race is just as fun and competitive as it was in person, just a whole lot safer. This 5K Run/Walk will Redefine Being Together. Learn how you can take part individually or by forming a virtual team at the link below.
register button
covid-19 vaccine
IMF Advocates for Cancer Patient Vaccine Prioritization
On January 26, 2021, the International Myeloma Foundation led a group of cancer advocacy organizations in sending a letter to states regarding COVID-19 vaccine prioritization for cancer patients. Because many cancer patients are especially vulnerable to the effects of COVID-19, we want to ensure that patients are prioritized above the general public. The IMF also joined in additional group efforts and sent a letter advocating for patients to the CDC’s Advisory Committee on Immunization Practices, which you can access at the button below.

You can also view more about vaccine recommendations for myeloma patients here, and view the letters here.
2020LearnMoreButton.png
Best of ASH 2020
Watch a Replay of the Best of ASH 2020 Webinar
In this webinar, Dr. Brian G.M. Durie discusses key takeaways from the 2020 American Society of Hematology (ASH) annual conference for patients, caregivers, and others.
2020WatchNowButton.png
ask doctor durie video image
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

COVID-19 FAQ #25: How can the “Swiss cheese” model help myeloma patients stay safe?
Watch Now
 
Clinical Trials
OCEAN Trial (Fully Accrued)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Search the Myeloma Matrix 2.0

Smart Patients: Join the Conversation
Upcoming Events
Learn More
Charity Rumble: Myelo-no-more!

Watch the Replay
“IMWG Conference Series: ASH 2020”

Watch the Replay
“Living Well with Myeloma” Webinar

Watch the Replay
IMF Patient & Family Webinar

Learn More
Winter Challenge

Click here to see all events
 

We Thank Our Sponsors:

Amgen; Bristol-Myers Squibb; Genentech; GSK; Karyopharm Therapeutics; Oncopeptides, Inc.;
Sanofi-Genzyme; and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
2020ButtonDonateBurg.png
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma

www.myeloma.org
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
1-800-452-2873
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page